CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
December 2021—Qiagen announced that the FDA has approved the Liaison QuantiFeron-TB Gold Plus assay for use on DiaSorin’s automated Liaison XS platform. The Liaison QuantiFeron-TB Gold Plus tests for interferon gamma released from T cells that have encountered TB. The assay was developed by Qiagen and DiaSorin to offer streamlined laboratory automation for latent TB screening.
The addition of the fully automated Liaison XS platform to the already approved use of this assay on the Liaison XL version expands the range of potential customers to include those at smaller health care clinics.
Pages: 1 2